WO2010010346A3 - Topical compositions for use during tooth eruption - Google Patents

Topical compositions for use during tooth eruption Download PDF

Info

Publication number
WO2010010346A3
WO2010010346A3 PCT/GB2009/001818 GB2009001818W WO2010010346A3 WO 2010010346 A3 WO2010010346 A3 WO 2010010346A3 GB 2009001818 W GB2009001818 W GB 2009001818W WO 2010010346 A3 WO2010010346 A3 WO 2010010346A3
Authority
WO
WIPO (PCT)
Prior art keywords
use during
topical compositions
during tooth
tooth eruption
eruption
Prior art date
Application number
PCT/GB2009/001818
Other languages
French (fr)
Other versions
WO2010010346A2 (en
Inventor
Marco Mastrodonato
Original Assignee
Sinclair Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Limited filed Critical Sinclair Pharmaceuticals Limited
Publication of WO2010010346A2 publication Critical patent/WO2010010346A2/en
Publication of WO2010010346A3 publication Critical patent/WO2010010346A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A composition comprising a glycosaminoglycan, or a pharmaceutically acceptable salt thereof, glycyrrhetinic acid and, together or separate, extract of Aloe vera and extract of saffron.
PCT/GB2009/001818 2008-07-24 2009-07-22 Topical compositions for use during tooth eruption WO2010010346A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0813589.9 2008-07-24
GBGB0813589.9A GB0813589D0 (en) 2008-07-24 2008-07-24 Composition

Publications (2)

Publication Number Publication Date
WO2010010346A2 WO2010010346A2 (en) 2010-01-28
WO2010010346A3 true WO2010010346A3 (en) 2010-03-25

Family

ID=39746889

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2009/001818 WO2010010346A2 (en) 2008-07-24 2009-07-22 Topical compositions for use during tooth eruption

Country Status (2)

Country Link
GB (1) GB0813589D0 (en)
WO (1) WO2010010346A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700048750A1 (en) * 2017-05-05 2018-11-05 Farm Procemsa S P A COMPOSITION FOR THE TREATMENT OF AFTE AND BUCCALE ULCERS
CN110141622B (en) * 2018-07-26 2022-03-11 杭州来米医疗科技有限公司 Traditional Chinese medicine composition for treating pain and preparation method and application thereof
CN110141621B (en) * 2018-07-26 2022-03-11 杭州来米医疗科技有限公司 Traditional Chinese medicine composition for treating pain and preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748022A (en) * 1985-03-25 1988-05-31 Busciglio John A Topical composition
WO2002009637A2 (en) * 2000-07-28 2002-02-07 Sinclair Pharmaceuticals Limited Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
JP2005213187A (en) * 2004-01-29 2005-08-11 Kose Corp Involucrin production promoter
JP2006117552A (en) * 2004-10-19 2006-05-11 Hayashibara Biochem Lab Inc Skin care preparation for photo-aging prevention
WO2009125182A1 (en) * 2008-04-10 2009-10-15 Prime Interaction Holdings Limited A product for topical administration

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748022A (en) * 1985-03-25 1988-05-31 Busciglio John A Topical composition
WO2002009637A2 (en) * 2000-07-28 2002-02-07 Sinclair Pharmaceuticals Limited Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
JP2005213187A (en) * 2004-01-29 2005-08-11 Kose Corp Involucrin production promoter
JP2006117552A (en) * 2004-10-19 2006-05-11 Hayashibara Biochem Lab Inc Skin care preparation for photo-aging prevention
WO2009125182A1 (en) * 2008-04-10 2009-10-15 Prime Interaction Holdings Limited A product for topical administration

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SINCLAIR: "T-go (SPHO220) - Gel that alleviates the symptoms of teething", ARTICLE, 16 March 2008 (2008-03-16), XP002553554, Retrieved from the Internet <URL:http://pharmalicensing.com/public/outlicensing/view/5428/t-go-spho220-gel-that-alleviates-the-symptoms-of-teething> [retrieved on 20091103] *

Also Published As

Publication number Publication date
WO2010010346A2 (en) 2010-01-28
GB0813589D0 (en) 2008-09-03

Similar Documents

Publication Publication Date Title
MX2011008171A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof.
HK1138840A1 (en) Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
MY148496A (en) Dpp iv inhibitor formulations
MY160456A (en) Benzodiazepine bromodomain inhibitor
GEP20207129B (en) Inhibitors of influenza viruses replication
WO2008124085A3 (en) Methods of using combinations of mek and jak-2 inhibitors
EP2513343A4 (en) Methods and compositions for treating inflammation of skin
WO2007106537A3 (en) Aminoquinolones as gsk-3 inhibitors
UA93709C2 (en) 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions
MX2010014041A (en) A crystalline form of posaconazole.
WO2010092088A3 (en) Use of hydrophobin as a spreading agent
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
WO2009121872A3 (en) Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
WO2012046030A3 (en) Phosphodiesterase inhibitors
TW200942524A (en) Novel aminomethyl benzene derivatives
WO2010128050A3 (en) Dihydroorotate - dehydrogenasee inhibitors as virostatic compounds
WO2014040052A3 (en) Glycyrrhetinic acid derivatives with anti-inflammatory activity
MX2010000266A (en) A method for decreasing symptoms of alcohol consumption.
WO2009035634A3 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors
WO2012148174A3 (en) Composition for topical application for preventing hair loss and stimulating hair growth
WO2009141541A3 (en) Use of kif13a and ap-1 inhibitors for inhibiting melanogenesis
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2008143649A3 (en) Novel oxazolidinone compounds as antiinfective agents
WO2012104240A3 (en) Cosmetic use
WO2010121675A3 (en) Thiazolyl-benzimidazoles

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09784770

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09784770

Country of ref document: EP

Kind code of ref document: A2